Employing mice with hepatocyte-specific deletion of Atg7, we observed that FGF21 produced by autophagy-deficient hepatocytes inhibits growth and proliferation of autophagy-deficient tumor, suggesting a potential therapeutic role of FGF21 or other factors released from autophagy-deficient tumor in the management of cancer. Here, FGF21 is linked to neoplasm.